Good syndrome is a rare form of acquired immunodeficiency that occurs in people with a thymoma, a tumor of the thymus gland. It was first described in 1954, and its hallmark is dangerously low levels of immunoglobulins (the antibodies your body uses to fight infections) alongside a thymus tumor, leaving affected individuals vulnerable to a wide and sometimes unusual range of infections.1PubMed Central. Thymoma and immunodeficiency (Good syndrome): a report of 2 unusual cases and review of the literature Because the condition is so uncommon, it is often diagnosed late, sometimes only after years of puzzling, recurrent illnesses that do not respond to standard treatment.
What Happens to the Immune System
Good syndrome attacks both arms of the immune system. On the antibody side, immunoglobulin levels plummet, a state called hypogammaglobulinemia. Peripheral B cells, the white blood cells responsible for making those antibodies, drop to very low or undetectable numbers. On the cellular side, the picture is also disrupted: CD4 T-cell counts fall, the normal ratio of CD4 to CD8 cells can flip, and T cells may respond poorly when challenged.2PubMed Central. What is Good’s syndrome? Immunological abnormalities in patients with thymoma This combined deficiency is what makes Good syndrome particularly dangerous compared to conditions that impair only one branch of immunity.
Research into why B cells vanish has pointed to a problem deep in the bone marrow. In Good syndrome patients, the earliest stages of B-cell development stall out after the pro-B-cell stage, meaning new B cells simply are not being produced in adequate numbers. This arrest is distinct from genetic conditions that block B-cell development at a slightly later step, which suggests a unique mechanism at work, though the precise trigger remains unclear.3PubMed. Precursor B-cell development in bone marrow of Good syndrome patients
More detailed immune profiling has confirmed the breadth of the problem. In one study, eight of nine Good syndrome patients had B-cell counts so low they were essentially undetectable. The same patients showed reduced natural killer cells, neutrophils, and several specialized T-cell subtypes involved in immune regulation, while an unusual expansion of a type of T cell called TCRγδ+ cells was observed.4Frontiers in Immunology. In-depth blood immune profiling of Good syndrome patients The practical result is an immune system with holes everywhere, making patients susceptible to an unusually broad variety of infections.
Infections That Raise Suspicion
The most common infections in Good syndrome involve the sinuses and lungs. Patients develop recurrent sinusitis, bronchitis, and pneumonia, often caused by encapsulated bacteria. A review of published cases found that respiratory infections were documented in the majority, with Haemophilus influenzae being the most frequently identified pathogen.5Medicine (United States). Infections in patients with immunodeficiency with thymoma (good syndrome): Report of 5 cases and review of the literature These infections tend to recur despite appropriate courses of antibiotics, which is often the first clue that something deeper is wrong.6PubMed Central. Good’s Syndrome Patients Hospitalized for Infections: A Single-Center Retrospective Study
What sets Good syndrome apart from a straightforward antibody deficiency is the added vulnerability to opportunistic infections, the kind normally seen in people with severe T-cell problems such as advanced HIV. Mucocutaneous candidiasis (persistent oral or esophageal yeast infections), cytomegalovirus (CMV), and Pneumocystis pneumonia are all well-documented complications.2PubMed Central. What is Good’s syndrome? Immunological abnormalities in patients with thymoma One case report described a patient presenting simultaneously with CMV pneumonitis and esophageal candidiasis, illustrating how multiple opportunistic organisms can strike at once when both cellular and humoral immunity are compromised.7PubMed Central. Good’s syndrome presenting with CMV pneumonitis and oesophageal candidiasis: A case report
Even with immunoglobulin replacement therapy in place, the cellular immune defects can allow severe viral and fungal infections to break through. One longitudinal study found that while immunoglobulin therapy effectively controlled routine sinopulmonary infections, the majority of patients still experienced severe systemic viral or fungal infections during follow-up, and opportunistic infections were the leading cause of death in the cohort.8PubMed. Unraveling the Natural History of Good’s Syndrome: A Progressive Adult Combined Immunodeficiency
Chronic Diarrhea and Gut Problems
Recurrent infections are not confined to the airways. Chronic diarrhea affects roughly half of Good syndrome patients and can be one of the most debilitating day-to-day symptoms.9PubMed Central. Beware of the Patient with Thymectomy: Good’s Syndrome in a Patient Presenting with Diarrhea In some cases, a specific gut pathogen can be identified, including Salmonella, Campylobacter, Giardia, and CMV. In other cases, no organism is found, and the diarrhea may stem from immune dysregulation in the gut lining itself.
Gastrointestinal symptoms sometimes dominate the clinical picture. One reported case involved a 55-year-old woman who developed chronic diarrhea three years after her thymoma was surgically removed, followed by recurrent severe pneumonia three years after that. Good syndrome was not diagnosed until both problems were considered together.10PubMed Central. A case report of Good syndrome: Diarrhea and dyspnea This delayed recognition is a recurring theme in the literature: because the syndrome is rare and its symptoms overlap with more common conditions, it often takes years and multiple specialists before the pieces come together.11PubMed Central. Good Syndrome, a rare cause of refractory chronic diarrhea and recurrent pneumonia in a Chinese patient after thymectomy
Autoimmune and Hematologic Complications
Thymomas are notorious for triggering autoimmune conditions, and Good syndrome patients are not exempt. Myasthenia gravis, which causes muscle weakness, is the most common autoimmune disorder associated with thymoma overall. It can occur alongside Good syndrome, though the combination is rare. One case report documented a patient with Good syndrome who also had subclinical myasthenia gravis detected by the presence of anti-acetylcholine receptor antibodies, alongside pure red cell aplasia.12PubMed Central. Good’s Syndrome With Pure Red Cell Aplasia and Subclinical Myasthenia Gravis: A Case Report and Review of Literature
Pure red cell aplasia (PRCA), a condition where the bone marrow stops producing red blood cells, is another paraneoplastic complication that can coexist with Good syndrome. Both are rare individually in thymoma patients, and their overlap is rarer still. Interestingly, the immunosuppressive drug cyclosporine appears to help with the red cell aplasia but does not improve the immunoglobulin deficiency, suggesting the two problems arise through different mechanisms.13PubMed Central. Pure Red Cell Aplasia Associated with Good Syndrome
Oral lichen planus, an inflammatory condition that causes painful erosions in the mouth, has also been linked to Good syndrome. A literature review found that the erosive form was by far the most common variety, affecting nearly nine in ten reported patients. The tongue was the most frequently involved site, and almost half of the patients had lesions outside the mouth as well.14PubMed Central. Oral Lichen Planus in Patients With Good’s Syndrome: A Literature Review For clinicians, oral lichen planus developing in a patient with a known or suspected thymoma should prompt investigation for Good syndrome.
How Good Syndrome Is Diagnosed
There is no single diagnostic test. The diagnosis rests on demonstrating hypogammaglobulinemia in the presence of a thymoma, along with reduced or absent peripheral B cells. Most patients present in middle age with a history of infections that have been escalating in frequency or severity. The thymoma may already be known, or it may be discovered incidentally during the workup for the immune deficiency.
A key part of the diagnostic process is ruling out other causes of low immunoglobulins, particularly common variable immunodeficiency (CVID), which is the most frequent primary antibody deficiency in adults and shares several clinical features with Good syndrome. The distinction matters because the two conditions have different prognoses and management considerations. Good syndrome almost exclusively affects adults, and peripheral B cells are severely reduced or absent. In CVID, which can also present in childhood, most patients retain a normal or only slightly reduced total B-cell count, though memory B cells are characteristically low.15PubMed Central. Good’s Syndrome: Time to Move on From Reviewing the Past Differences in patterns of T-cell abnormalities and the presence of blood-cell cytopenias can further help distinguish the two.
The thymoma itself tends to be of specific subtypes. In one study of Good syndrome patients, three of five had type A thymomas and two had type AB, both relatively indolent histologic types.16PubMed Central. B cell deficiency in thymoma tissues of Good’s syndrome patients This is worth noting because it means the thymoma in Good syndrome is often not aggressively malignant in itself. The threat comes from the immune damage it causes, not from the tumor spreading.
Why Surgery Alone Is Not Enough
Removing the thymoma is generally the first step in management, both for cancer control and because the tumor’s ongoing presence may drive further immune disruption. However, thymectomy does not reverse the immunodeficiency. Immunoglobulin levels and B-cell counts typically remain low after surgery, and the susceptibility to infections persists.17PubMed Central. COVID-19 and Good’s Syndrome After Thymectomy Some patients develop Good syndrome only after the thymoma has been removed, sometimes years later, reinforcing the idea that the damage to the immune system, once established, is self-sustaining.
This is a point that can catch both patients and clinicians off guard. After successful thymoma surgery, the expectation might be that immune function will recover. The persistence of hypogammaglobulinemia post-thymectomy is one of the defining features that separates Good syndrome from transient perioperative immune changes. Any patient with a thymoma history who develops recurrent infections, even long after surgery, should have their immunoglobulin levels checked.
Long-Term Management
The backbone of Good syndrome management is immunoglobulin replacement therapy, delivered either intravenously (IVIG) or subcutaneously. The goal is to maintain adequate trough levels of IgG so that the body has a functional pool of borrowed antibodies at all times. In a study from a Thai referral hospital, all patients received monthly IVIG at a standard dose, achieving a mean trough IgG level of 881 mg/dL, and seven patients had favorable clinical outcomes with reduced infections.18PubMed. Features and outcomes of immunoglobulin therapy in patients with Good syndrome at Thailand’s largest tertiary referral hospital Another report documented infection-free survival for at least a year after IVIG was started in a patient who had been experiencing recurrent severe infections.19PubMed. Intravenous immunoglobulin replacement therapy to prevent pulmonary infection in a patient with Good’s syndrome
Immunoglobulin replacement primarily addresses the humoral (antibody) side of the deficiency. Because Good syndrome also involves cellular immune defects, additional preventive strategies are needed. These can include targeted antimicrobial prophylaxis against organisms like Pneumocystis (often with trimethoprim-sulfamethoxazole) and antifungal prophylaxis when indicated. Vaccination strategies may be discussed, though the response to vaccines is often poor given the underlying B-cell and T-cell defects.20PubMed. Prevention of infectious diseases in patients with Good syndrome
The longitudinal study mentioned earlier found that even with immunoglobulin replacement, many patients eventually developed progressive bronchiectasis (permanent damage and widening of the airways from repeated infections) and persistent splenomegaly. Three patients developed basal cell skin cancers. The cellular immune deficit, which immunoglobulin infusions cannot address, remained the main driver of serious complications over time.8PubMed. Unraveling the Natural History of Good’s Syndrome: A Progressive Adult Combined Immunodeficiency
Prognosis and What Drives Outcomes
Good syndrome carries a meaningful impact on survival. One study found a median survival of 14 years after diagnosis, with five-year survival at about 82% compared to 95% for age-matched population controls.21PubMed. Prognosis of Good syndrome: mortality and morbidity of thymoma associated immunodeficiency in perspective Infection is the overwhelming cause of death: a systematic review found that among Good syndrome patients who died, 92% died from infections.22PubMed Central. When the Good Syndrome Goes Bad: A Systematic Literature Review
The same review identified several factors that were independently associated with higher mortality risk. Active thymoma disease (meaning the tumor had not been fully controlled) roughly quadrupled the odds of death. Infections associated with cellular immune defects, infections of the central nervous system, and bloodstream infections were all strong predictors of a poor outcome.22PubMed Central. When the Good Syndrome Goes Bad: A Systematic Literature Review Sinopulmonary tract infections, while the most common type, were also significantly associated with mortality when they accumulated, likely reflecting the progressive lung damage that comes with repeated bouts of pneumonia and bronchitis.
These findings underscore two practical points. First, controlling the thymoma surgically (and with adjuvant therapy if needed) matters not just for cancer outcomes but for immune-related survival. Second, preventing infections, particularly the opportunistic and systemic ones, is the single most impactful thing clinicians can do. Early and aggressive use of immunoglobulin replacement, antimicrobial prophylaxis, and close surveillance for signs of infection are the pillars of care.
How Good Syndrome Differs From CVID in Practice
Because CVID is roughly a hundred times more common than Good syndrome, many immunologists encounter it regularly, while Good syndrome remains something most will see only a handful of times. The clinical overlap is substantial: both conditions feature low immunoglobulins, recurrent sinopulmonary infections, chronic diarrhea, and autoimmune complications. The distinction is not merely academic. CVID patients generally retain some B-cell function and tend to respond better to vaccines, while Good syndrome patients have a combined deficiency that makes them vulnerable to the opportunistic infections typically absent in CVID.15PubMed Central. Good’s Syndrome: Time to Move on From Reviewing the Past
In practice, the strongest diagnostic clue is the thymoma. Any adult presenting with new-onset hypogammaglobulinemia should have chest imaging, and any patient with a known thymoma and recurrent infections should have immunoglobulin levels drawn. The pattern of near-absent peripheral B cells, combined with a thymoma and clinical features of both humoral and cellular immunodeficiency, clinches the diagnosis. Because the immunodeficiency can emerge before, during, or years after the thymoma is discovered, the connection between the two is not always immediately obvious.5Medicine (United States). Infections in patients with immunodeficiency with thymoma (good syndrome): Report of 5 cases and review of the literature
Living With Good Syndrome
Day-to-day life with Good syndrome revolves around infection prevention. Immunoglobulin infusions are typically given every three to four weeks if intravenous, or weekly if subcutaneous, and need to continue indefinitely. Many patients learn to administer subcutaneous infusions at home, which reduces the burden of hospital visits. Routine monitoring includes periodic immunoglobulin trough levels, complete blood counts to watch for cytopenias, and imaging as needed to track the thymoma and look for complications like bronchiectasis.
Patients are advised to avoid high-risk exposures when feasible. Prompt evaluation for any febrile illness is important because infections can escalate quickly in the setting of combined immunodeficiency. The role of prophylactic antibiotics and antifungals varies by patient and should be tailored based on the individual’s history of infections and degree of T-cell impairment. Travel to regions with endemic opportunistic infections warrants extra caution and advance planning with an immunologist or infectious disease specialist.
A frustrating aspect of Good syndrome for patients is the lack of a cure. Unlike some forms of immunodeficiency where bone marrow transplant or gene therapy offers a path to immune reconstitution, there is no established curative treatment for Good syndrome. The B-cell development arrest in the bone marrow appears to be self-perpetuating even after the thymoma is removed.3PubMed. Precursor B-cell development in bone marrow of Good syndrome patients Research into the underlying mechanism is ongoing, but for now, lifelong replacement therapy and vigilant infection management remain the standard of care.